19 August 2020
Latham Advises Momenta on US$6.5 Billion Acquisition by Johnson & Johnson
Advising firms
Deal team
18 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Scott Shean Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Peter Handrinos Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Darren Guttenberg | Latham & Watkins LLP | Associate | corporate | Not stated |
| Christopher Lee | Latham & Watkins LLP | Associate | corporate | Not stated |
| Shannon Cheng | Latham & Watkins LLP | Associate | corporate | Not stated |
| Christopher Martinez | Latham & Watkins LLP | Associate | corporate | Not stated |
| Michael Egge | Latham & Watkins LLP | Partner | antitrust | Not stated |
| Patrick English | Latham & Watkins LLP | Counsel | antitrust | Not stated |
| Barrett Tenbarge | Latham & Watkins LLP | Associate | antitrust | Not stated |
| Matthew Conway | Latham & Watkins LLP | Partner | benefits and compensation | Not stated |
| Nikhil Kumar | Latham & Watkins LLP | Associate | benefits and compensation | Not stated |
| Lisa Watts | Latham & Watkins LLP | Partner | tax | Not stated |
| Shruti Hazra | Latham & Watkins LLP | Associate | tax | Not stated |
| Alan Tamarelli | Latham & Watkins LLP | Partner | intellectual property | Not stated |
| Elizabeth Richards | Latham & Watkins LLP | Partner | regulatory | Not stated |
| Betty Pang | Latham & Watkins LLP | Counsel | regulatory | Not stated |
| Nathan Beaton | Latham & Watkins LLP | Associate | regulatory | Not stated |
| Jenna Cooper | Latham & Watkins LLP | Partner | general corporate | Not stated |
15 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 6.50bn (US$6.5 billion)
- What the figure measures
- Enterprise value
- Client
- Momenta Pharmaceuticals, Inc.Sell-side
- Counterparties
- Johnson & Johnson (Buy-side)